PharmAust Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported revenue was AUD 0.861302 million compared to AUD 0.967199 million a year ago. Net loss was AUD 0.389244 million compared to AUD 0.021184 million a year ago.

Basic loss per share from continuing operations was AUD 0.0046 compared to AUD 0.0002 a year ago. Diluted loss per share from continuing operations was AUD 0.0046 compared to AUD 0.0002 a year ago.